Shoulder Innovations, Inc. (SI) |
| 17.8 -0.09 (-0.5%) 09-17 16:00 |
| Open: | 18.07 |
| High: | 18.07 |
| Low: | 17.41 |
| Volume: | 155,708 |
| Market Cap: | 369(M) |
| PE Ratio: | -10.29 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Specialties |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 23.32 |
| Resistance 1: | 21.05 |
| Pivot price: | 19.64 |
| Support 1: | 17.37 |
| Support 2: | 14.45 |
| 52w High: | 24.595 |
| 52w Low: | 10.92 |
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 16 Sep 2026
Shoulder Innovations Partners with ALM Ortho on Bespoke Titanium Implants for Complex Shoulder Cases - 3dprintingindustry.com
Tue, 15 Sep 2026
SI: Product innovation, robotics, and strong execution drive growth and margin expansion - TradingView
Mon, 14 Sep 2026
Shoulder innovations CEO Robert Ball sells $187,706 in stock - Investing.com
Mon, 14 Sep 2026
Shareholder plans $187,706 stock sale in Shoulder Innovations (SI) - Stock Titan
Thu, 10 Sep 2026
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch - PR Newswire
Thu, 10 Sep 2026
About 10% to 15% of people test positive for metal sensitivity. Shoulder Innovations launches an implant. - Stock Titan
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
